Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial

Archive ouverte

Derache, A. | Iwuji, C. C. | Baisley, K. | Danaviah, S. | Marcelin, A. G. | Calvez, V. | de Oliveira, T. | Dabis, Francois | Porter, K. | Pillay, D.

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Background: Previous studies in HIV-positive individuals on thymidine analogue backbone antiretroviral therapy (ART) with either nevirapine or efavirenz have suggested poorer virological outcomes in the presence of pretreatment drug resistance (PDR). We assessed the impact of PDR on virological suppression (VS) [<50copies/mL] in individuals prescribed primarily tenofovir/emtricitabine/efavirenz in rural KwaZulu-Natal within a Treatment as Prevention trial. Methods: Among 1,557 HIV-positive individuals reporting no prior ART at study entry and provided plasma samples, 1,328 individuals with entry viral load (VL) >1,000 copies/mL had next generation sequencing (NGS) of the HIV pol gene with MiSeq technology. Results were obtained for 1,148 individuals and the presence of PDR assessed at 5% and 20% detection thresholds. Virological outcome was assessed using Cox regression in 837 of 920 ART initiators with at least one follow-up VL after ART initiation. Results: PDR prevalence was 9.5% (109/1,148) and 12.8% (147/1,148) at 20% and 5% thresholds respectively. After a median of 1.36years (IQR 0.91-2.13), mostly on fixed-dose combination (FDC) tenofovir/emtricitabine/efavirenz, presence of both NRTI/NNRTI PDR vs. no PDR was associated with longer time to VS [aHR 0.32, 95%CI=0.12-0.86] while there was no difference between those with only NNRTI PDR vs. no PDR [aHR 1.05, 95%CI=0.82-1.34] at the 5% threshold. Similar differences were observed for mutations detected at the 20% threshold, although without statistical significance. Conclusions: NGS uncovered a high prevalence of PDR amongst participants enrolled in trial clinics in rural KwaZulu-Natal. Dual class PDR to a mainly tenofovir/emtricitabine/efavirenz was associated with poorer VS. However, there was no impact of NNRTI PDR alone.

Suggestions

Du même auteur

Linkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort study. : BMJ Open

Archive ouverte | Siedner, M. J. | CCSD

International audience. OBJECTIVES: The expanding burden of non-communicable diseases (NCDs) globally will require novel public health strategies. Community-based screening has been promoted to augment efficiency of...

Osteonecrosis of the jaw induced by arsenic trioxide therapy in a leukemia patient: A rare case report and literature review

Archive ouverte | Derache, A. | CCSD

International audience

Genomic and epidemiological monitoring of yellow fever virus transmission potential

Archive ouverte | Faria, N. R. | CCSD

International audience. The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablis...

Chargement des enrichissements...